News articles about Evogene (NYSE:EVGN) have trended somewhat positive on Monday, Accern Sentiment Analysis reports. The research group ranks the sentiment of news coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Evogene earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 47.2797670134279 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.
Evogene (NYSE EVGN) opened at 4.80 on Monday. The company’s market capitalization is $123.58 million. Evogene has a 12 month low of $4.57 and a 12 month high of $7.09. The stock’s 50 day moving average is $5.03 and its 200-day moving average is $5.15.
Evogene (NYSE:EVGN) last announced its quarterly earnings results on Thursday, August 10th. The biotechnology company reported ($0.18) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.13) by $0.05. Evogene had a negative net margin of 235.47% and a negative return on equity of 18.60%. The business had revenue of $1.18 million during the quarter. On average, analysts expect that Evogene will post ($0.71) EPS for the current year.
COPYRIGHT VIOLATION WARNING: “Evogene (NYSE:EVGN) Receives News Impact Score of 0.22” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://stocknewstimes.com/2017/08/14/evogene-nyseevgn-receives-news-impact-score-of-0-22.html.
Evogene Company Profile
Evogene Ltd. (Evogene) is a biotechnology company for the improvement of crop productivity. The Company is engaged in developing seed traits for improved yield and abiotic stress tolerance, seed traits for biotic stress resistance, herbicides and bio-stimulants. The Company operates a seed business under its subsidiary Evofuel Ltd.
Receive News & Ratings for Evogene Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evogene Ltd and related companies with MarketBeat.com's FREE daily email newsletter.
